A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, parallel group, multicenter clinical study to evaluate
the efficacy, safety, pharmacokinetics and immunogenicity of LBEC0101 compared to Enbrel in
subjects with active Rheumatoid Arthritis despite Methotrexate therapy.